Cresco Labs (CRLBF) Enterprise Value (2019 - 2026)
Cresco Labs' (CRLBF) quarterly Enterprise Value came in at -$155.4 million in Q1 2026, down 72.86% YoY from -$572.6 million in Q1 2025, and up 13.21% on a QoQ basis from -$179.0 million in Q4 2025.
Cresco Labs (CRLBF) Enterprise Value (2019 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 8 years of Enterprise Value data on file, last reported at -$155.4 million in Q1 2026.
- Quarterly Enterprise Value fell 72.86% year-over-year to -$155.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$155.4 million (down 58.02% YoY) and the FY2025 annual result came in at -$179.0 million, down 98.67% from the prior year.
- Enterprise Value grew to -$155.4 million in Q1 2026, from -$179.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$15.9 million in Q2 2022 to a low of -$209.1 million in Q2 2024.
- A 5-year average of -$104.3 million and a median of -$89.9 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value surged 88.87% — and 2023, when it slumped 379.69%.
- Tracing CRLBF's Enterprise Value over 5 years: stood at -$39.4 million in 2022, then plunged by 372.98% to -$186.1 million in 2023, then soared by 51.59% to -$90.1 million in 2024, then sank by 98.67% to -$179.0 million in 2025, then gained by 13.21% to -$155.4 million in 2026.
- The last three Enterprise Value figures came in at -$155.4 million (Q1 2026), -$179.0 million (Q4 2025), and -$121.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Cresco Labs | 290.46 Mn | 226.34 Mn | 86.95 Mn | -159.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -155.39 Mn |
| Dec 31, 2025 | -179.03 Mn |
| Sep 30, 2025 | -121.46 Mn |
| Jun 30, 2025 | -86.71 Mn |
| Mar 31, 2025 | -89.89 Mn |
| Dec 31, 2024 | -90.12 Mn |
| Sep 30, 2024 | -94.78 Mn |
| Jun 30, 2024 | -209.11 Mn |
| Mar 31, 2024 | -85.08 Mn |
| Dec 31, 2023 | -186.15 Mn |
| Sep 30, 2023 | -80.43 Mn |
| Jun 30, 2023 | -76.39 Mn |
| Mar 31, 2023 | -54.04 Mn |
| Dec 31, 2022 | -39.36 Mn |
| Sep 30, 2022 | -17.87 Mn |
| Jun 30, 2022 | -15.93 Mn |
| Mar 31, 2022 | -191.57 Mn |
| Dec 31, 2021 | 37.06 Mn |
| Sep 30, 2021 | -160.51 Mn |
| Jun 30, 2021 | -135.23 Mn |